While Surgery Partners Inc has underperformed by -1.89%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SGRY fell by -20.25%, with highs and lows ranging from $45.79 to $22.05, whereas the simple moving average fell by -15.76% in the last 200 days.
On March 06, 2024, Barclays started tracking Surgery Partners Inc (NASDAQ: SGRY) recommending Equal Weight. A report published by TD Cowen on November 14, 2023, Upgraded its rating to ‘Outperform’ for SGRY. BofA Securities also Upgraded SGRY shares as ‘Buy’, setting a target price of $45 on the company’s shares in a report dated June 02, 2023. Mizuho Initiated an Buy rating on May 12, 2023, and assigned a price target of $48. Cantor Fitzgerald initiated its ‘Overweight’ rating for SGRY, as published in its report on April 21, 2023. RBC Capital Mkts’s report from November 23, 2022 suggests a price prediction of $48 for SGRY shares, giving the stock a ‘Outperform’ rating. BofA Securities also rated the stock as ‘Neutral’.
Analysis of Surgery Partners Inc (SGRY)
Further, the quarter-over-quarter increase in sales is 4.00%, showing a positive trend in the upcoming months.
There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Surgery Partners Inc’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of -0.60% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.57, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
As an indicator of volatility for any stock, average volume can also be very valuable, and SGRY is recording an average volume of 929.05K. On a monthly basis, the volatility of the stock is set at 3.29%, whereas on a weekly basis, it is put at 3.24%, with a loss of -5.82% over the past seven days. Furthermore, long-term investors anticipate a median target price of $43.00, showing growth from the present price of $27.49, which can serve as yet another indication of whether SGRY is worth investing in or should be passed over.
How Do You Analyze Surgery Partners Inc Shares?
Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 42.33%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 66.10% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
SGRY shares are owned by institutional investors to the tune of 66.10% at present.
